About Valentis
Valentis is a company based in Vilnius (Lithuania) founded in 1919. It operates as a Private Labeling / White Label and Contract Manufacturing. Valentis offers products and services including Microcapsulated Products, Immunity Products, Contract Manufacturing, and Private Label.
- Headquarter Vilnius, Lithuania
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website valentis.com
- Social LinkedIn Facebook
- Legal Name Valentis Ag
- Latest Funding Round$13.8M (USD), Post-IPO
Jan 2002
Products & Services of Valentis
Valentis offers a comprehensive portfolio of products and services, including Microcapsulated Products, Immunity Products, Contract Manufacturing, and Private Label.
Innovative health solutions are offered in microcapsulated forms.
Products for immunity support are developed and sold.
Manufacturing services for pharmaceuticals are provided to clients.
Branded products under private labels are produced here.
Funding Insights of Valentis
- Total Rounds 1
- Last Round Post-IPO — $13.8M
- First Round $13.8M
(Jan 2002)
All 1 funding rounds of Valentis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2002 | $13.8M | Post-IPO | – | – | – |
Timeline of Valentis
3 dated milestones of Valentis across 83 years, from founding to its latest funding, stage changes and deals.
- Founded Valentis is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $13.8M.
Web traffic of Valentis
Websites that share an audience with Valentis (valentis.com).
Websites whose visitors overlap most with Valentis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gintarine.lt | 100% | 1.5M | #39,187 | View details | |
pharmacydepot.gr | pharmacydepot.gr | 79% | – | #1,533,889 | – |
efarmakeio.gr | efarmakeio.gr | 79% | – | #1,822,484 | – |
profertil.eu | profertil.eu | 78% | – | #4,998,538 | – |
| nutritionx.co.uk | 71% | – | #685,058 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Valentis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Valentis
10 companies that operate in the same segment as Valentis (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Valentis
Valentis was founded in 1919 and raised its 1st funding round 83 years after it was founded.
Valentis is headquartered in Vilnius, Lithuania.
Valentis is focused on the development and manufacturing of natural health products and pharmaceuticals. Operations are conducted in key therapeutic areas with over 250 innovative products. Production capacity exceeds 15 million packages annually across two units. Services such as contract manufacturing, private labeling, and logistics are provided. Emphasis is placed on natural and safe treatments that support the human bodys balance. Extensive scientific research underpins product efficacy, ensuring minimal harm to both individuals and the environment. The company operates in multiple countries across Europe.
Valentis offers Microcapsulated Products, Immunity Products, Contract Manufacturing, and Private Label.
Valentis operates through Valentis Ag.